ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MDXG MiMedx Group Inc

6.16
-0.17 (-2.69%)
After Hours
Last Updated: 15:07:17
Delayed by 15 minutes

Period:

Draw Mode:

Volume 542,394
Bid Price 6.11
Ask Price 6.95
News -
Day High 6.39

Low
3.31

52 Week Range

High
9.27

Day Low 6.155
Share Name Share Symbol Market Stock Type
MiMedx Group Inc MDXG NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.17 -2.69% 6.16 15:07:17
Open Price Low Price High Price Close Price Previous Close
6.34 6.155 6.39 6.16 6.33
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
8,013 542,394 US$ 6.26 US$ 3,393,889 - 3.31 - 9.27
Last Trade Type Quantity Price Currency
15:20:00 formt 452 US$ 6.16 USD

MiMedx Group Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
906.73M 146.96M - 321.48M 58.23M 0.40 15.57
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

MiMedx News

Date Time Source News Article
4/16/202407:00GlobeNewswire Inc.MIMEDX to Host First Quarter 2024 Operating and Financial..
3/27/202407:00GlobeNewswire Inc.MIMEDX Provides Update on AXIOFILL® Request for Designation..
3/20/202406:00GlobeNewswire Inc.MIMEDX Expands Portfolio with Fibrillar Collagen Wound..
3/13/202407:00GlobeNewswire Inc.MIMEDX Introduces E-Commerce and Account Management Platform
3/05/202417:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/05/202417:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/05/202417:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/04/202407:11Edgar (US Regulatory)Form 8-K - Current report
3/04/202407:00GlobeNewswire Inc.MIMEDX Announces Appointment of Two New Independent..
2/28/202415:22Edgar (US Regulatory)Form 8-K - Current report
2/28/202415:02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/28/202415:01GlobeNewswire Inc.MIMEDX Announces Fourth Quarter and Full Year 2023 Operating..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No MDXG Message Board. Create One! See More Posts on MDXG Message Board See More Message Board Posts

Historical MDXG Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week6.616.6356.1556.41649,989-0.45-6.81%
1 Month8.278.436.1557.14828,523-2.11-25.51%
3 Months8.199.03946.1557.75807,193-2.03-24.79%
6 Months6.619.275.577.69726,990-0.45-6.81%
1 Year3.429.273.317.15741,2802.7480.12%
3 Years11.5215.992.436.58678,101-5.36-46.53%
5 Years6.7415.992.436.95694,106-0.58-8.61%

MiMedx Description

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, MiMedx sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Your Recent History

Delayed Upgrade Clock